Citation: F. Cicchetti et al., SINGLE-AXON LABELING STUDY OF THE NIGROSTRIATAL DOPAMINERGIC SYSTEM -POSSIBLE CLUES TO PARKINSONS-DISEASE PATHOLOGY, Brain pathology, 8(3), 1998, pp. 581-581
Citation: A. Parent et F. Cicchetti, THE CURRENT MODEL OF BASAL GANGLIA ORGANIZATION UNDER SCRUTINY - REPLY, Movement disorders, 13(6), 1998, pp. 982-982
Citation: F. Cicchetti et al., DIFFERENTIAL EXPRESSION OF GLUTAMATE-RECEPTOR MAY EXPLAIN THE SPARINGOF CALRETININ-CONTAINING STRIATAL INTERNEURONS IN HUNTINGTONS-DISEASE, Brain pathology, 7(3), 1997, pp. 1017-1017
Authors:
SIEGFRIED J
BLOND S
BENABID A
DESTEE A
FRANCKE JP
KERAVEL Y
NGUYEN JP
PARENT A
RASCOL O
CASSIM F
CICCHETTI F
DEFEBVRE L
FABRE N
MARTINAT P
PRUVO JP
SABATINI U
SIGAL R
TAUB E
KELLY PJ
Citation: J. Siegfried et al., SOCIETE-DE-NEUROCHIRURGIE-DE-LANGUE-FRANC AISE, 47TH ANNUAL-MEETING, MARRAKECH, 25-28 1997 - NEUROSURGICAL TREATMENT OF PARKINSONS-DISEASE AND OTHER MOVEMENT-DISORDERS, Neuro-chirurgie, 43, 1997, pp. 7
Citation: Pv. Gould et al., SELECTIVE SPARING AND IMMUNOHISTOCHEMICAL CHARACTERIZATION OF STRIATAL CALRETININ-INTERNEURONS IN HUNTINGTONS-DISEASE, Journal of neuropathology and experimental neurology, 56(5), 1997, pp. 72-72
Citation: F. Cicchetti et al., SELECTIVE SPARING OF STRIATAL CALRETININ-IMMUNOREACTIVE NEURONS IN HUNTINGTONS-DISEASE, Brain pathology, 6(3), 1996, pp. 350-350
Citation: A. Parent et al., IMMUNOCYTOCHEMICAL CHARACTERIZATION OF NEURONS EXPRESSING CALRETININ IN HUMAN STRIATUM, Brain pathology, 6(3), 1996, pp. 355-355
Citation: F. Cicchetti et A. Parent, STRIATAL INTERNEURONS IN HUNTINGTONS-DISEASE - SELECTIVE INCREASE IN THE DENSITY OF CALRETININ-IMMUNOREACTIVE MEDIUM-SIZED NEURONS, Movement disorders, 11(6), 1996, pp. 619-626
Citation: F. Cicchetti et al., SPARING OF STRIATAL NEURONS COEXPRESSING CALRETININ AND SUBSTANCE-P (NK1) RECEPTOR IN HUNTINGTONS-DISEASE, Brain research, 730(1-2), 1996, pp. 232-237
Citation: A. Parent et al., STRIATAL NEURONS DISPLAYING SUBSTANCE-P (NK1) RECEPTOR IMMUNOREACTIVITY IN HUMAN AND NONHUMAN-PRIMATES, NeuroReport, 6(5), 1995, pp. 721-724
Authors:
ACCONCIA A
ALCINI E
AMBROSETTI A
ANELLO A
ANSALDI N
ARAGONA C
BACCARANI C
BARTOLOTTA G
BEGANI R
BOCCONGELLI A
BOTTI C
BRUTTINI G
BULGARELLA A
CAMPO B
CASADEI G
CATANZARO F
CAVALIERE V
CERRUTI G
CICALESE V
CICCHETTI F
CICCU M
COLLOI D
COMERI G
CRUCIANI E
DANDREA G
DALESSANDRO E
DEJOANNA F
DEGRANDE G
DISANTO V
DURVAL A
FABBRI G
FERRARI P
FINI M
FIORE A
FLORIS F
FONTANA B
FONTE A
FRANCH L
FRATTA M
GALFANO G
GUARNA A
LAI S
LAVELLI D
LOZZI V
MACALUSO G
MACCANICO A
MANGANELLI A
MARTINI E
MASI C
MIANO L
MONDAINI F
MURARO G
NOCELLI V
PACIFICO P
PALLADINI P
PAOLETTI G
PAOLINI R
PARMA A
PASCUCCI L
PEGORARO V
PELLEGRINO A
PESCATORE D
PETRACCO S
PIAZZA B
PRIVITERA O
PUTTI F
RICCIARDI R
ROBLES A
ROMAGNOLI R
SACCA E
SALOMONE M
SALVEMINI C
SAMMARCO C
SANTORELLI V
SCARPA R
STIGLIANI V
STRIANO V
TOMBOLINI P
TONINI G
TORCHIANA B
TROCINO S
TUVERI A
VANCINI G
VICINI D
VIGGIANO G
VOCE S
ZAPPASODI W
Citation: A. Acconcia et al., MULTICENTER OBSERVATIONAL TRIAL ON SYMPTOMATIC TREATMENT OF BENIGN PROSTATIC HYPERPLASIA WITH ALFUZOSIN - CLINICAL-EVALUATION OF IMPACT ON PATIENTS QUALITY-OF-LIFE, European urology, 27(2), 1995, pp. 128-134
Authors:
BACCARANICONTRI M
VINCENZI D
CICCHETTI F
MORI G
PASQUALIRONCHETTI I
Citation: M. Baccaranicontri et al., IMMUNOCHEMICAL IDENTIFICATION OF ABNORMAL CONSTITUENTS IN THE DERMIS OF PSEUDOXANTHOMA ELASTICUM PATIENTS, European journal of histochemistry, 38(2), 1994, pp. 111-123
Authors:
SCAGLIONE F
CICCHETTI F
DEMARTINI G
ARCIDIACONO M
Citation: F. Scaglione et al., FOSFOMYCIN DISTRIBUTION IN THE LOWER URINARY-TRACT AFTER ADMINISTRATION OF FOSFOMYCIN TROMETAMOL SALT, International journal of clinical pharmacology research, 14(3), 1994, pp. 107-109